Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule… - Bmj, 2020 - bmj.com
Objective To assess the effectiveness of hydroxychloroquine in patients admitted to hospital
with coronavirus disease 2019 (covid-19) pneumonia who require oxygen. Design …

Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know

J Yazdany, AHJ Kim - Annals of internal medicine, 2020 - acpjournals.org
Two medications often used for treatment of immune-mediated conditions,
hydroxychloroquine and chloroquine, have recently attracted widespread interest as …

COVID-19 and rheumatology: first steps towards a different future?

IB McInnes - Annals of the rheumatic diseases, 2020 - ard.bmj.com
As a rheumatology community, we looked on the new decade with excitement and ambition
yet now instead find ourselves amidst the most significant global public healthcare …

Fatal arrhythmias: another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19

I Uzelac, S Iravanian, H Ashikaga, NK Bhatia… - Heart rhythm, 2020 - Elsevier
Background Early during the current coronavirus disease 19 (COVID-19) pandemic,
hydroxychloroquine (HCQ) received a significant amount of attention as a potential antiviral …

A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients

F Askarian, Z Firoozi, A Ebadollahi-Natanzi… - Toxicological …, 2022 - Springer
Abstract The SARS-CoV-2 virus, caused a novel emerged coronavirus disease, is growing
rapidly worldwide. Few studies have evaluated the efficacy and safety of Chloroquine (CQ) …

Coronavirus disease-19 and rheumatological disorders: A narrative review

A Chattopadhyay, D Mishra, V Sharma… - Indian Journal of …, 2020 - journals.lww.com
The global spread of coronavirus disease-19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2, which originated from Wuhan, China, is likely to have …

Biomedical research in times of emergency: lessons from history

D Doroshow, S Podolsky, J Barr - Annals of Internal Medicine, 2020 - acpjournals.org
Coronavirus disease 2019 (COVID-19) has sickened millions, killed hundreds of thousands,
and utterly disrupted the daily lives of billions of people around the world. In an effort to …

Hydroxychloroquine versus azithromycin for hospitalized patients with suspected or confirmed COVID-19 (HAHPS). Protocol for a pragmatic, open-label, active …

SM Brown, ID Peltan, B Webb, N Kumar… - Annals of the …, 2020 - atsjournals.org
Coronavirus disease (COVID-19) is a potentially fatal illness with no proven therapy beyond
excellent supportive care. Treatments are urgently sought. Adaptations to traditional trial …

Hydroxychloroquine for coronavirus: The urgent need for a moratorium on prescriptions

RD Shih, HM Johnson, DG Maki… - The American Journal of …, 2020 - amjmed.com
Many issues concerning the prescription of chloroquine and hydroxychloroquine in the
treatment and prevention of coronavirus 2019 (COVID-19) have been addressed in recent …

Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?

S Moiseev, S Avdeev, M Brovko, P Novikov… - Annals of the …, 2021 - ard.bmj.com
In a recent article, Spinelli et al discussed a potential role of antimalarials in prevention of
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and suggest that …